PCOS diagnostic Market, By Type of Diagnostic Test (Hormone Test, Imaging Tests, Blood Tests, Pelvic Examination, Genetic Testing, Other Tests), By End-User (Hospitals & Clinics, Fertility Clinics, Homecare Settings, Diagnostic Laboratories), By Geography

PCOS diagnostic Market, By Type of Diagnostic Test (Hormone Test, Imaging Tests, Blood Tests, Pelvic Examination, Genetic Testing, Other Tests), By End-User (Hospitals & Clinics, Fertility Clinics, Homecare Settings, Diagnostic Laboratories), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

PCOS is a hormonal disorder that affects 1 in 10 women of childbearing age. It can cause irregular periods, trouble getting pregnant, and hair growth on the face and body. This condition results in irregular menstrual cycles, abnormal ovulation, high androgen levels, enlarged ovaries, and insulin resistance. It has been found to affect 5 million women of reproductive age globally. It also causes serious complications such as infertility, rheumatoid arthritis, high blood pressure, heart disease, and diabetes.

Market Dynamics:

Surging cases of the PCOS condition, increasing prevalence of PCOS, and increased awareness among women about its symptoms are expected to drive growth of the global PCOS diagnostic market over the forecast period. Other factors, including obesity, a sedentary lifestyle, and hormonal disorders, are also expected to drive the market’s growth.

However, stringent regulatory approval processes for PCOS disease drugs and the side effects of treatment drugs are expected to hinder growth of the global PCOS diagnostic market over the forecast period.

For instance, on June 28, 2023, according to data provided by the World Health Organization, PCOS a significant public health problem and is one of the commonest hormonal disturbances affecting women of reproductive age. The condition affects an estimated 8–13% of women of reproductive age, and up to 70% of cases are undiagnosed worldwide. The prevalence of PCOS is higher among some ethnicities, and these groups often experience more complications, as in particular those related to metabolic problems.

Key features of the study:

• This report provides in-depth analysis of the global PCOS diagnostic market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global PCOS diagnostic market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Abbott, Quest Diagnostics, Thermo Fisher Scientific, Inc., Siemens Healthineers, Bio-Rad Laboratories, Hologic, Inc., Vitrolife, Myriad Genetics, Inc., Ansh Labs, Diagnostica Stago Inc., Beckman Coulter, Inc., Randox Laboratories Ltd., GE Healthcare, PrivaPath Diagnostics, Laboratory Corporation of America Holdings, SRL Diagnostics
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global PCOS diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global PCOS diagnostic market

Detailed Segmentation:

• PCOS Diagnostic Market, By Type of Diagnostic Test:
• Hormone Test
• Imaging Tests
• Blood Tests
• Pelvic Examination
• Genetic Testing
• Other Tests
• PCOS Diagnostic Market, By End User:
• Hospitals and Clinics
• Fertility Clinics
• Homecare Settings
• Diagnostic Laboratories
• PCOS Diagnostic Market, By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa
• Company Profile:
• F. Hoffmann-La Roche Ltd
• Abbott
• Quest Diagnostics
• Thermo Fisher Scientific, Inc.
• Siemens Healthineers
• Bio-Rad Laboratories
• Hologic, Inc.
• Vitrolife
• Myriad Genetics, Inc.
• Ansh Labs
• Diagnostica Stago Inc.
• Beckman Coulter, Inc.
• Randox Laboratories Ltd.
• GE Healthcare
• PrivaPath Diagnostics
• Laboratory Corporation of America Holdings
• SRL Diagnostics